CHRASTINA, Jan, Ondřej HORÁK, Michal RYZÍ, Milan BRÁZDIL, Zdeněk NOVÁK, Tomáš ZEMAN a Pavlína DANHOFER. Single-center long-term results of vagus nerve stimulation for pediatric epilepsy: a 10-17-year follow-up study. Childs nervous system. NEW YORK: SPRINGER, 2023, roč. 39, č. 11, s. 3215-3224. ISSN 0256-7040. Dostupné z: https://dx.doi.org/10.1007/s00381-023-05992-3.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Single-center long-term results of vagus nerve stimulation for pediatric epilepsy: a 10-17-year follow-up study
Autoři CHRASTINA, Jan (203 Česká republika, garant, domácí), Ondřej HORÁK (203 Česká republika, domácí), Michal RYZÍ (203 Česká republika, domácí), Milan BRÁZDIL (203 Česká republika, domácí), Zdeněk NOVÁK (203 Česká republika, domácí), Tomáš ZEMAN (203 Česká republika, domácí) a Pavlína DANHOFER (203 Česká republika, domácí).
Vydání Childs nervous system, NEW YORK, SPRINGER, 2023, 0256-7040.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30210 Clinical neurology
Stát vydavatele Spojené státy
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 1.400 v roce 2022
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1007/s00381-023-05992-3
UT WoS 000992036000001
Klíčová slova anglicky Seizure; Stimulation treatment; Stimulation responder; Palliative surgery
Štítky 14110127, 14110131, 14110320, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Eva Dubská, učo 77638. Změněno: 14. 2. 2024 19:56.
Anotace
PurposeA retrospective study, based on a prospectively built database, presents the results of long-term follow-up care of pediatric vagus nerve stimulation (VNS) patients in terms of seizure outcome, surgical aspects, the potential impact of maturation, and medication changes.MethodsFrom a prospectively built database, 16 VNS patients (median age 12.0 years, range 6.0 to 16.0 years; median seizure duration 6.5 years, range 2.0 to 15.5 years) followed for at least 10 years were graded as non-responder - NR (seizure frequency reduction < 50%), responder - R (reduction >= 50% and < 80%), and 80% responder - 80R (reduction >= 80%). Data about surgical aspects (battery replacement, system complications), seizure dynamics, and medication changes were taken from the database.ResultsThe early percentages of good results (80R + R) were 43.8% (year 1), 50.0% (year 2), and 43.8% (year 3). These percentages remained stable between years 10 and 12 (50% year 10; 46.7% year 11; 50% year 12) and increased in years 16 (60%) and 17 (75%). Depleted batteries were replaced in ten patients, six of whom were either R or 80R. In the four NR, the indication for replacement was improved quality of life. Three patients had VNS explanted or switched off-one had repeated asystolia and two were NR. The effect of hormonal changes in menarche on seizure was not proven. During the study, antiseizure medication was changed in all patients.ConclusionsThe study proved the efficacy and safety of VNS in pediatric patients over an exceptionally long follow-up period. The demand for battery replacements indicates a positive treatment effect.
Návaznosti
NV19-04-00343, projekt VaVNázev: Predikce Efektu Stimulace u pacientů s Epilepsií (PRESEnCE) (Akronym: PRESEnCE)
Investor: Ministerstvo zdravotnictví ČR, Prediction of Stimulation Efficacy in Epilepsy
VytisknoutZobrazeno: 30. 4. 2024 20:48